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Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in young
children. The factors that contribute to the increased propensity of RSV-induced distal
airway disease compared with other commonly encountered respiratory viruses remain
unclear. Here, we identified the RSV-encoded nonstructural 2 (NS2) protein as a viral
genetic determinant for initiating RSV-induced distal airway obstruction. Infection of human
cartilaginous airway epithelium (HAE) and a hamster model of disease with recombinant
respiratory viruses revealed that NS2 promotes shedding of infected epithelial cells,
resulting in two consequences of virus infection. First, epithelial cell shedding accelerated
the reduction of virus titers, presumably by clearing virus-infected cells from airway mucosa.
Second, epithelial cells shedding into the narrow-diameter bronchiolar airway lumens
resulted in rapid accumulation of detached, pleomorphic epithelial cells, leading to acute
distal airway obstruction. Together, these data indicate that RSV infection of the airway
epithelium, via the action of NS2, promotes epithelial cell shedding, which not only
accelerates viral clearance but also contributes to acute obstruction of the distal airways.
Our results identify RSV NS2 as a contributing factor for the enhanced propensity of RSV to
cause severe airway disease in young children and suggest NS2 as a potential therapeutic
target for reducing the severity of distal airway disease.
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Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in young children. The factors
that contribute to the increased propensity of RSV-induced distal airway disease compared with other commonly encountered respiratory viruses remain unclear. Here, we identified the RSV-encoded nonstructural 2
(NS2) protein as a viral genetic determinant for initiating RSV-induced distal airway obstruction. Infection of
human cartilaginous airway epithelium (HAE) and a hamster model of disease with recombinant respiratory
viruses revealed that NS2 promotes shedding of infected epithelial cells, resulting in two consequences of
virus infection. First, epithelial cell shedding accelerated the reduction of virus titers, presumably by clearing
virus-infected cells from airway mucosa. Second, epithelial cells shedding into the narrow-diameter bronchiolar airway lumens resulted in rapid accumulation of detached, pleomorphic epithelial cells, leading to acute
distal airway obstruction. Together, these data indicate that RSV infection of the airway epithelium, via the
action of NS2, promotes epithelial cell shedding, which not only accelerates viral clearance but also contributes to acute obstruction of the distal airways. Our results identify RSV NS2 as a contributing factor for the
enhanced propensity of RSV to cause severe airway disease in young children and suggest NS2 as a potential
therapeutic target for reducing the severity of distal airway disease.
Introduction
Human respiratory syncytial virus (RSV) is a nonsegmented, negative-sense, single-stranded RNA virus belonging to the family
Paramyxoviridae, subfamily Pneumovirinae. RSV is the most common virus responsible for acute and severe lower airway disease in
infants and young children, with nearly all children experiencing
at least one RSV infection by the age of 2 years (1). While most RSV
infections present with mild to moderate self-limiting pulmonary
symptoms, in approximately 2% of cases, especially in infants who
are very young (<3 months), premature, or who have underlying
immunodeficiency or cardiopulmonary disease, lower airway disease is severe enough to require hospitalization (2). Worldwide, an
estimated 34 million new pediatric cases of RSV-associated lower
airway disease occur annually, accounting for approximately
200,000 deaths, almost all of which occur in developing countries
with reduced access to standardized care (3).
Despite significant impact of RSV infection on infant morbidity and mortality, treatment options remain limited largely
to supportive care. Ribavirin is the only antiviral drug currently
approved for treating RSV infections, but issues of efficacy,
delivery, and toxicity restrict its use to immunocompromised
patients (4). Bronchodilators and anti-inflammatory steroids
are widely prescribed to dampen the inflammatory consequences of RSV infection, despite evidence that these treatments
provide little to no clinical benefit (5–7). Prophylactic use of pasConflict of interest: The authors have declared that no conflict of interest exists.
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sively administered neutralizing antibodies is effective in reducing RSV-associated hospitalization in susceptible populations,
but these antibody treatments are expensive and inconvenient,
and are limited to at-risk infants (8, 9). Licensed RSV vaccines
are currently unavailable but are under active development. The
high incidence of RSV infection and the potential for severe distal airway disease in vulnerable young children, combined with
limited availability of therapeutic options, identifies a significant global human health need.
RSV infects the mucosal epithelium lining the human respiratory tract, predominantly targeting the columnar epithelial
cells of the conducting airways. The columnar airway epithelium
provides critical innate defense functions important for maintaining lung sterility. Airway epithelial cells respond to inhaled
pathogens by secreting antimicrobials and recruiting inflammatory cell infiltrates important for clearing infection and subsequent tissue repair. The airway epithelium also uniquely provides
mechanical clearance of inhaled pathogens by facilitating unidirectional mucus transport, largely due to synchronous beating of
cilia and regulated mucin secretion. Precisely how RSV infection
affects innate functions of the columnar airway epithelium and
how this relates to subsequent RSV-associated disease is poorly
defined, largely due to the limited availability of human airway
pathology specimens obtained during early RSV infection. In
the limited postmortem studies available from RSV-infected
infants, it was noted that epithelial cells positive for RSV antigen were sloughed into the lumens of infected airways, leading
to speculation that intralumenal accumulations of infected and
necrotic epithelial cells could contribute to airway obstruction
and inflammation, exacerbating airway disease (10–12). Whether
sloughing of airway epithelial cells was a direct consequence of
RSV-induced epithelial cell cytopathology or a bystander effect
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Figure 1
RSV-GFP infection, replication,
and clearance in HAE cultures.
(A) Representative en face fluorescent images of GFP-positive
cells in HAE infected with RSV
expressing GFP at days 1, 3, 5,
and 7 pi. Scale bar: 200 μm. (B)
The number of RSV-infected cells
in HAE over time, quantified as
the percentage of the epithelium
surface area positive for GFP
fluorescence. (C) Virus titers
present in the airway surface fluid
over time. Data (mean ± SEM)
are representative of independent
experiments utilizing at least 4
cultures per donor obtained from
3 different donors.

of the robust infiltration of inflammatory cells into the infected
airways has been difficult to decipher in the complex in vivo environment of the lung.
We previously described an in vitro model of RSV infection of
human cartilaginous airway epithelium (HAE) that recapitulates
the cellular distribution and physiology of the human differentiated airway epithelium. Using this model, we and others have
shown that RSV infects and spreads in HAE by preferentially
infecting ciliated epithelial cells while sparing mucin-containing Goblet cells and the underlying basal epithelial cells (13, 14).
These in vitro findings are supported by histologic studies of cartilaginous airways from RSV-infected patients that also demonstrate the preferential tropism of RSV for ciliated cells (10). Tropism for ciliated cells is not unique to RSV, as other RNA viruses,
including paramyxoviruses, coronaviruses, and avian influenza
viruses, have been shown to preferentially infect ciliated cells in
the HAE model (15–17).
Our previous studies demonstrated that RSV infection of
human ciliated cells in HAE was minimally cytopathic, at least
within the first 48 hours of infection (14). The lack of direct
RSV-induced cytopathology was in contrast to the rapid and
robust cytopathology documented in HAE infected by influenza
viruses (18). In the present study, we have expanded our earlier
studies with RSV to track the fate of RSV-infected ciliated cells
over time and to determine consequences of infection potentially
important for pathogenesis. By tracking the fate of ciliated cells
infected by RSV in vitro, we identified a unique consequence of
RSV infection whereby infected ciliated cells rapidly transitioned
from a columnar to a rounded cell morphology and were then
extruded from the otherwise intact epithelium. Once shed, the
detached RSV-infected cells were incorporated into lumenal
mucus secretions of HAE and were transported by the directional
flow of mucus secretions. Using RSV gene deletion mutants, ciliated cell rounding after RSV infection was attributed to the RSV
non-structural 2 (NS2) protein. Gain-of-function experiments
using recombinant, GFP-expressing parainfluenza virus 3 (PIV32220

GFP) engineered to express RSV NS2 (PIV3-NS2) demonstrated
that ciliated cells infected with PIV3-NS2, but not with PIV3,
became rounded and morphologically indistinguishable from
ciliated cells infected with RSV. To explore potential in vivo functions of RSV NS2 expression, we infected the airways of Golden
Syrian hamsters with PIV3-NS2 or PIV3 and show that PIV3-NS2
caused rapid shedding of infected epithelial cells from the airway epithelium, which coincided with accelerated clearance of
virus infection from hamster lungs. These studies also revealed
an unexpected consequence of PIV3-NS2 infection of the narrower-diameter bronchiolar airways, in which PIV3-NS2 but not PIV3
caused sufficient intralumenal accumulations of shed epithelial
cells to partially or fully occlude the bronchiolar airway lumens.
These findings suggest that acute, distal airway obstruction, a
common feature of RSV infection in infants, may be due to the
rapid shedding of RSV-infected bronchiolar epithelial cells into
the airway lumen and that this event is a direct consequence of
RSV NS2 expression. To our knowledge, these studies provide the
first description of the unique fate of RSV-infected columnar airway epithelial cells and identify a novel property of the RSV NS2
protein as promoting this event.
Results
Kinetics of RSV replication in HAE. The kinetics of RSV infection in
HAE was measured by inoculating the apical surface of cultures
with a recombinant RSV expressing GFP inserted between the
phosphoprotein (P) and matrix (M) genes (3 × 105 PFU; MOI ~1),
and the numbers of GFP-positive cells and titers of released virus
were determined every 24 hours for 8 days. Representative en face
images of GFP-positive cells and quantification of the percentage
of epithelium surface area positive for GFP across HAE obtained
from multiple tissue donors are shown in Figure 1, A and B,
respectively. At day 1 post-inoculation (pi), RSV infection resulted
in 5% of the epithelium surface area positive for GFP, and over
time the extent of infection steadily increased as virus infection
spread, with 53% of the epithelium surface area being GFP-positive
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cells, and by day 8 pi, virus titers had fallen by 2 logs
compared to those at day 4 pi (Figure 1C). The rapid net
loss of RSV infection from HAE between days 4 and 8 pi
suggests that most of the RSV-infected ciliated cells were
cleared from the epithelium during this period and, as
HAE are pure populations of epithelial cells, that clearance of infected ciliated cells occurred in the absence of
immune cell–mediated clearance mechanisms.
A distinctive morphologic change in RSV-infected columnar airway cells. To investigate how RSV-infected (GFPpositive) ciliated cells were cleared from HAE, we used histologic analysis to track the fate of infected ciliated cells
over time. These studies revealed that RSV-infected ciliated cells underwent a distinctive morphologic transition
from the native columnar cell morphology to a rounded
cell morphology while remaining embedded in the epithelium (Figure 2A). Ciliated epithelial cells of both human
cartilaginous airway epithelium in vivo and HAE cultures
in vitro are characteristically columnar, with individual
ciliated cells spanning the depth of the epithelium and
the ciliated cell tail intercalating into the underlying basal
epithelial cell layers. Histologic assessment of ciliated cell
rounding in vitro revealed that RSV infection caused a
rapid retraction of the ciliated cell tails, which resulted
in the infected cell assuming a rounded shape. Only
GFP-positive ciliated cells (i.e., infected with RSV) exhibited rounded cell morphology, and no GFP-positive cells
were observed that retained the native columnar shape of
ciliated cells, suggesting that ciliated cell rounding was a
direct consequence of RSV infection.
Figure 2
Ciliated cells infected by RSV also began to bulge from
Morphologic and structural changes in RSV-infected ciliated columnar cells. the epithelial layer into the lumenal compartment and
(A) Representative histologic sections of HAE inoculated with RSV expresswere eventually extruded from the epithelium (Figure 2A).
ing GFP and counterstained with H&E or immunoprobed for GFP (green) and
β-tubulin IV (red) at days 1, 3, and 5 pi. Yellow outlines at top left depict the differ- During the extrusion process, the bulging apical mement ciliated cell morphologies seen in RSV-infected HAE, where noninfected cili- branes of RSV-infected cells progressively lost apical
ated cells are columnar and RSV-infected ciliated cells exhibit rounded morphol- structural components of ciliated cells, including cilia, as
ogy. Arrowheads indicate robust apical terminal web in noninfected ciliated cells demonstrated by loss of β-tubulin IV immunoreactivity
(top left), which thins in RSV-infected ciliated cells with rounded morphology (top (Figure 2A) and a marked thinning of the cytoskeletal terright). Images are representative of independent experiments with 4 different minal web (see arrows in Figure 2A). Despite significant
donor cultures. Scale bar: 10 μm. (B) Representative TEM of cross-sections of disruption of apical structures in these bulging ciliated
the apical surfaces of noninfected (left) and RSV-GFP–infected (center, right)
cells, the cells retained GFP fluorescence, suggesting that
HAE. Arrowhead indicates particulates showing virus-like morphology. Asterisk
plasma membrane permeability was not overtly comproindicates disorganized basal bodies. Scale bars: 1 μm.
mised (Figure 2A). High-power transmission electron
microscopy (TEM) studies of noninfected and RSV-inby day 4 pi. Beyond day 4 pi, the numbers of GFP-positive cells fected HAE, fixed to preserve the hydrated external environdeclined rapidly, and by day 8 pi, infected cell numbers approxi- ment of the HAE lumenal surface, confirmed that RSV infection
mated those at day 1 pi In agreement with previous studies (14), resulted in the disintegration of apical structures, most notably
only ciliated cells expressed GFP, which confirmed RSV tropism cilia shafts and microvilli (Figure 2B). Basal bodies, usually orgafor ciliated cells in this model. On average, ciliated cells repre- nized directly below emerging cilia shafts, were often disorgasented approximately 90% of the surface columnar epithelial cells nized in the cytoplasm of RSV-infected ciliated cells (asterisk in
in HAE, indicating that approximately 60% of available ciliated Figure 2B). Clouds of particulate matter in the external lumenal
cells were infected by RSV at the time of maximal infection (day 4). environment were composed of fragmented cilia and microvilli
Throughout infection, HAE cultures remained intact based on directly above bulging RSV-infected ciliated cells. It is reasonable
to presume that these particulate clouds also contain progeny
gross visual inspection, as previously described (14, 17).
RSV titers in washes harvested from the apical surfaces of RSV virions and, on occasion, structures resembling RSV virions
HAE paralleled the numbers of GFP-positive cells (Figure 1C). were detected (arrow in Figure 2B). More conclusive identificaRSV titers steadily increased proportionate to the numbers of tion of RSV virions in these clouds was technically challenging,
GFP-positive cells during the first 3 days of infection, reaching as immunogold labeling of virus proteins would not discriminate
maximal titers by day 4 pi (2.6 × 106 PFU/ml). Once maximal, between infectious progeny virions and virus proteins associated
virus titers declined proportionate to the loss of GFP-positive with fragmented cellular debris.
The Journal of Clinical Investigation   http://www.jci.org   Volume 124   Number 5   May 2014
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consistently increased in RSV-infected
HAE cultures, reaching maximal levels
at days 5 to 7 pi Amounts of dsDNA in
apical washes from noninfected HAE
remained low and constant over the
same time period. The increased dsDNA
in apical washes closely correlated with
the loss of GFP-positive epithelial cells
from HAE (Figure 1B), indicating the
usefulness of dsDNA as a marker for
the numbers of shed epithelial cells in
airway secretions in vitro.
Overall, these observations suggest
that the loss of GFP-positive cells from
RSV-infected HAE is predominately
due to shedding of the infected ciliated
cells from the airway mucosa. RSVinfected epithelial cells, while rounded
and extruding from the epithelium,
exhibited no obvious nuclear abnormalities (Figure 3A) and were negative
for TUNEL staining (data not shown),
indicating that infected cells during
the shedding process remained viable.
Figure 3
Infected cells also retained GFP fluoresCiliated cell shedding and loss of cilia activity during RSV-GFP infection of HAE. (A) Representative
cence, suggesting that the plasma memimages of histological cross-sections of noninfected HAE (top) or HAE infected with RSV expressing
GFP (bottom) fixed at day 5 pi using a fixation protocol to preserve the content and depth of airway brane of infected cells remained intact.
surface secretions. Scale bar: 20 μm. (B) Concentration of dsDNA as an index for numbers of shed In contrast, shed and detached epithecells present in apical washes harvested every 24 hours from noninfected (white circles) or RSV- lial cells in mucus secretions on the apiinfected (black squares) HAE. Data (mean ± SEM) were derived from 4 cultures per donor for 4 dif- cal surface of HAE displayed well-charferent donors. (C) Fluorescent bead velocity as an index of mucus transport rates on the apical sur- acterized nuclear structural changes
faces of noninfected (white circles) or RSV-infected (black squares) HAE at indicated times pi. Data indicative of cell death, and pykno(mean ± SEM) represent 3–6 cultures per donor for 3 different donors. (D) Surface area of active
sis (nuclear shrinkage), karyorrhexis
cilia beat on noninfected (white circles) or RSV-infected (black squares) HAE. Data (mean ± SEM)
(nuclear fragmentation), and karyolyrepresent 4 cultures. Data in B–D show significant differences at day 3 pi (P < 0.05) and at all time
sis (nuclear dissolution) were noted in
points thereafter (P < 0.001), as determined by unpaired t test.
shed epithelial cells (Figure 3A). These
findings demonstrate that RSV-infected
Shedding of epithelial cells from RSV-infected HAE. To further assess ciliated cells do not undergo overt cell death while embedded in the
the cytopathology of RSV-infected cells, we examined histologic epithelium and that cell death in situ does not play a significant role
sections of noninfected and RSV-infected HAE fixed to preserve in the clearance of RSV-infected cells from HAE. Rather, infected
airway surface secretions accumulated over a 5-day period. In cells undergo cell death after becoming completely detached from
noninfected HAE, only occasional detached epithelial cells were the epithelium, although we have not been able to determine the
present in accumulated mucus secretions (Figure 3A, top). In con- precise kinetics of when shed cells die. We have also been unable to
trast, RSV-infected cultures contained large numbers of detached identify cellular mechanisms leading to death of shed cells. Neverepithelial cells embedded in an increased mucus layer (Figure 3A, theless, since the reduction of RSV titers in HAE paralleled the loss
bottom). In addition to the increased number of detached cells of GFP-positive cells, we propose that shedding of RSV-infected ciliin mucus secretions, the underlying intact epithelium of RSV- ated cells, and not death while cells are embedded in the epithelium,
infected cultures was irregular in appearance, largely due to the represents the primary mechanism for clearing RSV infection from
rounded morphology of infected ciliated cells remaining in the a differentiated airway epithelium, at least in vitro.
Effects of RSV infection on mucociliary transport. Extensive shedding
epithelium. An overall decrease in cilia abundance also was noted
of cells onto the lumenal surface of RSV-infected HAE suggests
in the RSV-infected epithelium.
We quantified the extent and kinetics of epithelial cell shedding that, in vivo, this cellular material may be cleared from the airway
from RSV-infected HAE cultures by determining the amount of lumen by mechanical clearance mechanisms, such as mucociliary
dsDNA present in daily washes of the lumenal surfaces of noninfected transport (MCT). In vitro, we often observed shed and detached
and RSV-infected HAE (Figure 3B). Apical washes consistently con- GFP-positive cells being transported within mucus secretions
tained increased amounts of dsDNA at day 1 pi for both noninfected across the surface of cultures. Since directional transport of mucus
(mock-inoculated) and RSV-infected HAE, which we attribute to secretions in HAE is dependent on coordinated cilia beat, the
consequences of the inoculation procedure. However, by day 3 pi, potential impact of RSV infection on the effectiveness of cilia functhere was a clear difference between RSV-infected and noninfected tion may adversely affect the ability of the airways to mechanically
HAE in the amount of dsDNA present in apical washes, as dsDNA clear infection. We tested the consequence of RSV infection on
2222
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Figure 4
RSV-induced ciliated cell rounding is unique to RSV infection and is
due to expression of the RSV NS2 protein. (A) Representative images
of histologic cross-sections of fixed and paraffin-embedded HAE
infected with recombinant RSV-GFP, low-passage clinical isolate RSV
Memphis 37, or recombinant PIV3-GFP. Infected cells were detected at
day 3 pi using an anti-RSV antibody or anti-PIV3 antibody, as appropriate. Scale bar: 10 μm. (B) Representative images of histologic crosssections of HAE infected with RSV, or gene deletion mutants RSVΔNS1
and RSVΔNS2. All viruses express GFP. (C and D) Height of infected
ciliated cells (mean ± SD) was determined using confocal microscopy
of fixed but unprocessed HAE infected with RSV, PIV3, HMPV, PIV5,
or SeV or the RSV gene deletion mutants RSVΔNS1, RSVΔNS2, and
RSVΔNS1/2. All viruses expressed GFP. At least 100 infected cells in
cultures obtained from 3 different donors were measured. *P < 0.05,
**P < 0.01, ***P < 0.001, 1-way ANOVA with Tukey’s post-hoc test.

directional transport of particulates present in airway secretions
by measuring MCT rates of 1-μm fluorescent beads transported
across the lumenal surface of HAE (Figure 3C). For noninfected
HAE, MCT rates of approximately 40 μm/s were maintained for
6 consecutive days of experimental analysis. For RSV-infected
HAE, MCT rates approximated those of noninfected HAE during the first 2 days of RSV infection, despite infection of approximately 20% of the epithelium surface. However, by day 3 pi, RSVinfected HAE demonstrated a significant decline in MCT rate, and
by day 4 pi, when approximately 60% of the epithelium surface
was infected, MCT rates had fallen drastically to below 5 μm/s.
By day 5 pi, bead transport in RSV-infected HAE had ceased.
To determine whether loss of MCT after RSV infection was
directly associated with loss of cilia function, we also quantified
the percentage of the epithelium surface that displayed beating
cilia at each time point (Figure 3D). In noninfected HAE, approximately 90% of the epithelium surface possessed active cilia, and
this level was maintained over 6 consecutive days of analysis. A
similar extent of cilia activity was measured during the first 2 days
of RSV infection, indicating that cilia activity of infected cells was
not significantly affected early during infection, similar to our
previous findings (14). However, beginning at day 3 pi, the area
of active cilia progressively declined, resulting in only 38% of the
epithelium surface displaying active cilia by day 5 pi and 10% by
day 6 pi. These results suggest that RSV infection has little effect
on the ability of the ciliated epithelium to generate MCT within
the first few days of infection. However, as the numbers of infected
cells increased and as infection of individual cells resulted in apical membrane cytopathology, RSV infection can abolish MCT.
We noted that at day 3 pi and day 4 pi, although the area of cilia

activity was high, MCT rates had rapidly declined. Such declines in
MCT rate prior to significant losses in the area of active cilia may
be explained by subtle but deleterious effects of RSV infection on
coordinated cilia beat, such as cilia beat asynchrony and subsequent disruption of unidirectional transport. Indeed, high-speed
video images of RSV-infected ciliated cells reveal visual evidence of
cilia beat asynchrony prior to the loss of cilia structures (Supplemental Figure 1 and Supplemental Video 1; supplemental material
available online with this article; doi:10.1172/JCI72948DS1).
Taken together, these data suggest that, at least until day 3 pi,
RSV-infected HAE cultures maintain sufficient MCT to transport
infected cells shed across the airway surface, and that cell shedding
may represent a previously unidentified mechanism to enhance
MCT-mediated clearance of RSV infection from the airways.
Cell rounding is unique to RSV among a number of common paramyxoviruses. We also investigated whether RSV-induced rounding of ciliated cells occurred following infection with other respiratory viruses
known to infect ciliated cells in HAE. Ciliated cells infected by PIV
serotypes 1, 2, 3, or 5, Sendai virus (SeV), or human metapneumovirus (HMPV) failed to exhibit ciliated cell rounding (Figure 4,
A and C, and data not shown). As an index of cell rounding, we
measured the height of GFP-positive cells using confocal microscopy xz sections. Ciliated cells infected by RSV were significantly
shorter, due to cell rounding, than those infected by the other GFPexpressing respiratory viruses that were tested (Figure 4C). Our
studies utilized a recombinant RSV A2 strain expressing GFP, and
we confirmed that cell rounding was not an artifact of the recombinant virus or expression of GFP, as a recombinant RSV without
GFP (GP1), the biologically derived RSV from which the recombinant was generated (HEp-4), and a wild-type RSV strain of subgroup B all caused rounding of infected ciliated cells identical to
the recombinant GFP-expressing virus (data not shown). Because
studies have described phenotypic differences between highly passaged RSV strains and clinical isolates, we confirmed that a recently
isolated, minimally passaged, clinical strain of RSV (RSV Memphis 37) caused infected ciliated cells to round with morphology
indistinguishable from those cells infected by recombinant GFPexpressing RSV (Figure 4A). Overall, these data suggest that ciliated
cell rounding is a unique consequence of RSV infection.
Columnar cell rounding is associated with expression of the NS2 gene.
We speculated that the unique morphologic phenotype induced
in ciliated cells by RSV infection might be due to the expression
of specific RSV genes. We explored this possibility by infecting
human ciliated cells with recombinant, GFP-expressing RSVs
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Figure 5
Expression of RSV NS2 in ciliated cells using PIV3 results in infected
cell rounding. (A) Growth kinetics of recombinant PIV3 (white circles)
and PIV3 expressing either RSV NS1 (PIV3-NS1, black squares),
NS2 (PIV3-NS2, white triangles) or both NS1 and NS2 (PIV3-NS1/2,
black triangles) in HAE. All viruses expressed GFP. Virus titers in apical washes were assessed at 24-hour intervals. Data (mean ± SEM)
represent 4 cultures per donor with cultures from 3 different donors.
(B) Representative images of histologic cross-sections of HAE infected
with PIV3, PIV3-NS1, PIV3-NS2, or PIV3-NS1/2. Infected cells were
detected with an anti-PIV3 antibody. Scale bar: 10 μm. (C) Height of
infected cells (mean ± SD) was determined as described in Figure 4.
*P < 0.05, **P < 0.01, 1-way ANOVA with Tukey’s post-hoc test.

from which individual viral genes had been deleted. These studies revealed that infection of ciliated cells by a mutant RSV with
deletion of the two NS genes, NS1 and NS2 (RSVΔNS1/2), failed
to cause rounding of infected ciliated cells (Figure 4D). Instead,
ciliated cells infected with this mutant retained the native columnar morphology and resembled the morphology of ciliated cells
infected by other respiratory viruses, such as PIV3. Evaluation
of RSV mutants deleted of NS1 or NS2 genes (RSVΔNS1 and
RSVΔNS2) showed that RSVΔNS1 induced ciliated cell rounding
indistinguishable from that of RSV expressing a full complement
of RSV genes, suggesting that NS1 was not responsible for the
cell-rounding phenotype (Figure 4, B and D). In contrast, ciliated
cells infected by RSVΔNS2 did not round and maintained columnar morphology identical to that following RSVΔNS1/2 infection
(Figure 4, B and D). These differential effects of the NS-deleted
viruses were not due to significant differences in mutant virus
replication, as both RSVΔNS1 and RSVΔNS2 were similarly attenuated for replication compared with RSV in cell lines (19) and
HAE (Supplemental Figure 2A). Overall, these experiments indicate that expression of NS2, in the context of RSV infection, is
necessary for RSV-induced ciliated cell rounding.
Expression of NS2 by recombinant PIV3 mimics RSV-induced cell
morphology. Since PIV3, like RSV, exclusively infects ciliated cells
in HAE cultures but does not cause rounding of ciliated cells, we
used recombinant PIV3 to deliver RSV NS1, NS2, or both genes
to ciliated cells in the absence of other RSV genes. Recombinant
PIV3 was engineered to express GFP and NS2 (PIV3-NS2), NS1
(PIV3-NS1), or both NS1 and NS2 (PIV3-NS1/2), and the consequences of infection compared with PIV3 expressing GFP alone
were assessed. In each case, GFP was inserted between the P and
M genes, and the RSV gene(s) were inserted between the HN and
L genes. All recombinants were readily recovered, and infection
and growth were assessed in non-polarized epithelial cell lines
and HAE cultures. In non-polarized epithelial cell lines, recombinant PIV3 viruses expressing RSV NS genes and GFP were slightly
attenuated for growth compared with PIV3 expressing GFP alone
(Supplemental Figure 2, B and C). Similar to cell lines, in HAE, all
2224

3 PIV3 viruses expressing RSV NS genes exhibited modest growth
attenuation compared with PIV3, despite similar levels of infection at day 1 pi (Figure 5A). Growth of PIV3-NS2 and PIV3-NS1
was equally attenuated in HAE, replicating to titers approximately
1 log lower than PIV3 at day 3 pi, the time of peak replication.
Growth of PIV3-NS1/2 was more severely attenuated, producing
titers 2 logs lower than PIV3 at the time of peak replication. This
observed attenuation presumably reflected the increased genome
length and gene number of the PIV3 viruses with inserted RSV NS
genes, although the possibility exists that the RSV NS proteins had
direct inhibitory effects on replication.
In HAE cultures, ciliated cells infected by PIV3 or PIV3-NS1
maintained native columnar morphology, whereas ciliated cells
infected by PIV3-NS2 or PIV3-NS1/2 underwent cell rounding,
with significantly shortened cell heights (Figure 5, B and C) and
closely resembled ciliated cell morphology after RSV infection.
The observation that PIV3-NS1/2 and PIV3-NS2 caused cell
rounding indistinguishable from that caused by RSV suggested
that NS2 mediated this effect independent of the expression of
NS1 or other RSV proteins.
NS2 expression adversely affects ciliated cell structure and function. In
addition to similar overall morphology of ciliated cells infected by
PIV3-NS2 and RSV, closer examination of ultrastructural features
of the apical surfaces of ciliated cells infected by PIV3-NS2 or PIV3NS1/2 recapitulated those of RSV-infected cells. Characteristics
of RSV-infected ciliated cells such as bulging apical membranes,
thinning of the terminal web, and loss of cilia and microvilli were
evident in, and indistinguishable between, ciliated cells infected by
RSV, PIV3-NS2, and PIV3-NS1/2 (Figure 6A).
Functional studies measuring the extent of cilia activity in
HAE infected by the recombinant viruses demonstrated that
PIV3-NS2 and PIV3-NS1/2 infection resulted in a marked
decline in the surface area of epithelium displaying cilia activity
within the first 4 days of infection (Figure 6B). In contrast, PIV3
infection did not affect the extent of cilia activity until day 5
pi. PIV3-NS1, despite robust infection, had little effect on cilia
activity within the 6 days of experimental analysis. These data
suggest that PIV3 infection was less cytopathic to cilia activity
compared with PIV3-NS2, indicating that NS2-promoted cell
rounding may also be associated with disruption of cilia or cilia
scaffolding complexes in infected cells. We also noted that NS1
may further reduce the moderate cytopathology evident after
PIV3 infection. These findings are intriguing, as they point to
divergent effects of RSV NS1 and NS2 on ciliated cell cytopathology. However, as noted above, experiments with PIV3-NS1/2
indicate these divergent effects of NS2 and NS1 expression on
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Figure 6
Expression of RSV NS2 by PIV3 in HAE cultures mimics RSV-induced
cytopathology at the apical surface of ciliated cells. (A) Representative images of histologic sections of noninfected HAE, or HAE infected
by RSV, PIV3, PIV3-NS1, PIV3-NS2, or PIV3-NS1/2 fixed at day 2 pi
showing similar apical membrane disruption in ciliated cells infected by
RSV, PIV3-NS2, and PIV3-NS1/2. Richardson’s counterstain was used.
Scale bar: 10 μm. (B) Surface area of active cilia beat on noninfected
HAE (black circles, dotted line) or HAE infected with PIV3 (white circles), PIV3-NS1 (black squares), PIV3-NS2 (white triangles), or PIV3NS1/2 (black triangles). Data (mean ± SEM) represent quadruplicate
cultures. All viruses expressed GFP.

ciliated cell cytopathology are dominated by the effects of NS2
when both NS proteins are expressed together, as occurs with
PIV3-NS1/2 or RSV infection.
Effects of RSV NS2 on PIV infection of airway epithelium in vivo. We next
used the PIV3 viruses expressing RSV NS genes to test the morphologic consequences of RSV NS2 expression in vivo. Because PIV3
poorly infects the airway epithelium of mice, we chose Golden Syrian hamsters as our in vivo model, as they are a well-documented
useful model of PIV3 airway infection (20). We first focused on the
hamster nasal respiratory airway epithelium, as this pseudostratified columnar epithelium contains ciliated and mucin-containing (goblet) cells at densities similar to those of columnar cells in
HAE cultures and human cartilaginous airway epithelium in vivo.
Hamsters were inoculated intranasally with PIV3, PIV3-NS2, or
PIV3-NS1 (106 PFU). Maximal virus titers were reached in the nasal
tissue by day 3 pi, and we observed equal but modest attenuation of
growth of PIV3-NS1 and PIV3-NS2 compared with PIV3 (Figure 7A),
similar to attenuation in HAE (Figure 5A).
Identification of virus-infected epithelial cells by immunodetection of PIV3 antigen in histologic sections of hamster nasal epithelium at day 3 pi showed that all recombinant PIV3 viruses infected
ciliated columnar cells but not mucin-containing Goblet columnar cells of the hamster nasal respiratory epithelium (Figure 7B).

While ciliated cells infected by PIV3 or PIV3-NS1 retained the
native columnar cell morphology, cells infected by PIV3-NS2
exhibited rounded cell morphology and resembled human ciliated
cells infected by PIV3-NS2 or RSV in vitro. Morphometric analysis
of infected ciliated cell height in histologic sections of hamster
nasal respiratory epithelium revealed a significant shortening of
ciliated cells infected by PIV3-NS2 compared with those infected
by PIV3 or PIV3-NS1 (Figure 7C), reproducing the phenotype seen
in HAE (Figure 5B). In PIV3-NS2–infected hamster nasal cavities, virus antigen–positive cells were occasionally observed while
shedding from the epithelium into the airway lumen, but unlike
what was observed in HAE, accumulations of shed, virus-infected
epithelial cells after PIV3-NS2 infection were rarely noted in the
nasal cavity, suggesting that epithelial cells shed from the epithelium were rapidly cleared from the airway lumen, presumably by
mechanical clearance mechanisms.
Next we compared the consequences of PIV3 and PIV3-NS2
infection in the lungs of hamsters. Because PIV3-NS1 infection
did not induce ciliated cell rounding in HAE or hamster nasal epithelium, we focused our lower airway studies on the comparison of
PIV3 versus PIV3-NS2 infection. In hamsters inoculated with PIV3,
histologic analysis of whole lungs after day 3 pi showed viral antigen distributed throughout the conducting airway epithelium of
the large bronchial and small bronchiolar airway regions (Figure 8,
A and B, respectively). Although virus antigen was occasionally
detected in cells of the alveolar regions, the majority of infected
cells were restricted to the conducting airways. PIV3-infected epithelial cells of both large and small airways retained columnar
morphology and remained embedded in the epithelium, similar
to PIV3-infected epithelial cells in HAE cultures.
In contrast, in hamsters infected by PIV3-NS2 for 3 days, all virus
antigen–positive cells in the larger-diameter airways were rounded
and either shedding from or fully detached from the underlying
intact epithelium (Figure 8A). The smaller-diameter bronchiolar
airways similarly showed extensive rounding and detachment of
epithelial cells infected by PIV3-NS2 (Figure 8B). Remarkably,
the bronchiolar airway lumens contained accumulations of shed,
virus antigen–positive cells (Figure 8B), the extent of which was
sufficient to cause partial to complete occlusion of the bronchiolar airway lumens (Figure 8C). Although shed cell accumulation
in bronchioles was dramatic at day 3 pi, it was also transient, and
by day 5 pi almost all evidence of bronchiolar airway occlusion
and infection was absent, suggesting that the cell accumulations
were effectively cleared from the airway lumens (Figure 8B). The
rapid clearance of virus-infected cells from within the bronchiolar airway lumen was also noted in the bronchial airways at day
5 pi (Figure 8A). In contrast to the consequences of PIV3-NS2
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Figure 7
PIV3-NS2 causes ciliated cell rounding in the hamster nasal respiratory epithelium in vivo. (A) The nasal epithelium of Golden Syrian hamsters was inoculated with 106 PFU of PIV3 (black circles), PIV3-NS1
(white squares), or PIV3-NS2 (black triangles), and virus titers in the
nasal turbinates were determined at day 3 pi. Data (mean ± SEM)
represent 3 independent experiments with a total of 9 to 12 animals.
(B) Representative images of histologic cross-sections of hamster
nasal respiratory epithelium infected with PIV3 (top), PIV3-NS1 (center), or PIV3-NS2 (bottom). Virus antigen was detected at day 3 pi with
an anti-PIV3 antibody. Scale bar: 10 μm. (C) Height of infected ciliated
cells (mean ± SD) was determined by measuring height of virus antigen–positive cells from fixed tissue sections, with at least 200 cells
analyzed across 3 individual animals. All viruses expressed GFP.
***P < 0.001, 1-way ANOVA with Tukey’s post-hoc test.

infection, the robust PIV3 infection of the bronchial and bronchiolar airway epithelium at day 3 pi remained largely unaltered
by day 5 pi, indicating that PIV3-infected cells were not cleared
from the epithelium as effectively as those infected by PIV3NS2 (Figure 8, A and B).
To determine whether the more effective clearance of virus-infected cells following PIV3-NS2 infection influenced viral load
in the lung, we harvested hamster lung tissues inoculated with
PIV3-NS2 or PIV3 at days 1, 2, 3, 5, and 7 pi and measured whole
lung virus titers. These data revealed a strong temporal correlation
between the extent of virus antigen–positive cells and lung viral
titers. Specifically, although PIV3 and PIV3-NS2 titers were similar
at days 1 and 2 pi, PIV3 titers declined by less than 1 log between
days 3 and 5 pi, whereas during the same time period PIV3NS2 titers rapidly fell by almost 3 logs (Figure 8D). Infection by
both viruses was completely cleared from the lungs by day 7 pi.
Throughout the experiments, hamsters showed no clinical signs
of illness, as reported in previous studies of PIV3 infection of hamster airways (20). This is not surprising given the semi-permissive
nature of PIV3 infection in this non-native host.
In contrast to HAE and hamster nasal epithelium studies in
which PIV3 only infected ciliated cells, we noted that PIV3 and
PIV3-NS2 infected both ciliated and non-ciliated columnar cells
in the lower airways. We also noted that PIV3-NS2–infected cells
shed into the small airways exhibited an unusual pleomorphic
morphology compared with cells shed from HAE or the hamster
nasal respiratory epithelium. Shed PIV3-NS2–infected lower airway cells were swollen and at times bi-nucleated, with cell bodies protruding from the intact epithelium into the airway lumen
(Figure 9A). Using cytokeratin 18 as an immunomarker for epithelial cells, we confirmed that the infected, shedding, and accumulated cells were epithelial cells, as expected (Figure 9A).
To ascertain whether the morphologic consequences of PIV3NS2 infection of hamster lower airways resembled those in lower
airways of humans infected by RSV, we probed histologic sections
of autopsy lung tissues obtained from RSV-infected patients for
viral antigen. Assessment of pseudostratified columnar airway epithelium, indicative of larger airway regions, showed clear evidence
2226

of RSV antigen–positive epithelial cells embedded in the epithelium, displaying shortened, rounded cell morphology (Supplemental Figure 3B). Occasionally, RSV antigen–positive cells were
also detected detached in the airway lumen, suggestive of shed,
virus-infected cells that had not fully cleared from the airway.
Examination of the distal bronchiolar airways revealed bronchiolar lumens partially or fully occluded by pleomorphic epithelial
cells positive for RSV antigen and in some cases in the process of
shedding into the airway lumen (Figure 9B, Supplemental Figure
3A). Swollen and bi-nucleated cells were also observed in the airway lumen of these regions. These observations indicated that the
morphologic changes, cell shedding, and small airway occlusions
observed in hamster distal airways infected by PIV3-NS2 resembled the consequences of RSV infection of human lower airways
detected in postmortem samples.
Discussion
RSV is the most important viral agent of lower airway disease
in infants and young children and is commonly associated with
severe bronchiolitis in these populations. In infants, bronchiolitis
caused by RSV is documented to be more severe and prolonged
than bronchiolitis caused by other etiologies, including PIVs or
rhinoviruses (21, 22). A recent study of young children with acute
respiratory illness found that those infected with RSV had twice
as many emergency room visits and 6 times more hospitalizations
than those with seasonal influenza virus infections (23). The reasons why RSV has a tendency toward increased frequency and
severity of distal small airway disease in infants compared with
other etiologies are unknown.
In vitro and in vivo studies have established that ciliated cells of
the human large cartilaginous airways are important targets for
RSV infection. The ciliated airway epithelium serves an important role in maintaining lung health, as it provides a mechanical
barrier against inhaled pathogens and contributes to clearance by
facilitating MCT. Precisely how RSV infection of the airway epithelium leads to airway disease is poorly defined, but has been
attributed to both direct virus-mediated epithelial cell cytopathology and exaggerated host immunopathology, especially excessive
neutrophil-associated inflammation (24). Other consequences of
RSV infection, such as incidence of wheezing and possible skewing
of future immune responses, have been reported (25, 26). Clinical
and preclinical studies have greatly increased our understanding
of RSV pathogenesis, but the early initiating aspects of RSV infection of the airway epithelium and the relationship to subsequent
airway pathology remain poorly defined.
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Figure 8
Distal airway obstruction and accelerated clearance of virus infection in hamsters infected by PIV3-NS2. (A and B) Representative images of
histologic cross sections of hamster large airways (A) and small airways (B) 3 days and 5 days after infection with PIV3 or PIV3-NS2. Note the
rapid loss of PIV3-NS2–infected cells from airways at 5 days pi, a time when PIV3 infection remained robust. Scale bar: 100 μm. (C) Morphometric quantitative analysis of distal airway cell accumulation in hamsters infected with PIV3 or PIV3-NS2 by measuring the percentage of crosssectional airway lumen surface area occupied by virus antigen–positive cells at day 3 pi. Histologic, antigen-stained whole lung sections from
6 animals were measured. Each column represents an individual animal, and each symbol represents occlusion of an individual airway. Statistical
analysis of the mean occlusion values of the two groups was used to determine significance. P < 0.01, Mann-Whitney U test. (D) Whole lung virus
loads in hamsters infected with PIV3 (black circles) or PIV3-NS2 (white squares) measured over time, demonstrating a more rapid clearance of
PIV3 infection when the virus expressed RSV NS2. Data (mean ± SEM) represent 3 independent experiments with a total of 4 to 9 animals per
time point. All viruses expressed GFP. ***P < 0.0001, unpaired t test.

Investigating the role of the airway epithelium in RSV pathogenesis has been impeded by the scarcity of representative models
of polarized and differentiated airway epithelium that are both
susceptible to human RSV infection and mimic the outcomes
of infection observed in RSV-infected human airways in vivo.
Indeed, most experiments modeling RSV infection of the airway epithelium rely on transformed, non-polarized epithelial
cell lines, which do not resemble the differentiated architecture
of airway epithelium in vivo. The widely available in vivo models, particularly small rodents, also poorly reproduce the consequences of RSV infection observed in human airways, largely due
to low infectivity of the conducting airway epithelium by RSV.
Species-specific RSV equivalents used in appropriate permissive
hosts, such as bovine RSV in calves, are useful models for understanding RSV pathogenesis, but differences between the human
and animal viruses and the human and animal hosts have been
documented and can complicate such analyses (27).
In the present study, we combined in vitro and in vivo models
of differentiated airway epithelium to assess the impact of RSV
infection on the integrity and function of the ciliated airway epi-

thelium. Using cultures of primary pseudostratified HAE cells
that closely resembled the epithelium of authentic airway tissue,
we showed that RSV infection of human ciliated cells resulted in
the development of a rounded cell morphology and distinct apical
surface cytopathology, followed by extrusion of the infected cells
from the epithelium. These effects were not observed in ciliated
cells infected by PIV3 or several other respiratory paramyxoviruses.
Once infected ciliated cells shed from the epithelium, these cells
were incorporated into mucus secretions and underwent cell
death. The shed cells and associated mucus secretions were transported across the airway surface by coordinated cilia beat.
The use of RSV gene-deletion mutants revealed that these
effects were due to expression of the RSV NS2 protein. Specifically, whereas ciliated cells infected by RSV became rounded,
ciliated cells infected with RSVΔNS2 maintained columnar morphology and remained embedded within the intact epithelium.
Because PIV3 also targeted ciliated cells but did not cause the cell
rounding phenotype, we used PIV3 as a vector to express RSV
genes in ciliated cells. This novel approach to study virus gene
expression in ciliated cells demonstrated that RSV NS2 expressed
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occlusions observed in the small airways of young
infants infected by RSV. We also note that studies
with RSV-infected infants have described infection
of the larger airways as patches or clusters of infected
cells, compared with more robust circumferential
infection reported in the distal airway epithelium
(10, 28). Our in vivo studies with PIV3-NS2 suggest
that patchy infection in large airways may represent
continuous shedding and clearance of infected cells
in these regions, while shedding and accumulation
may perpetuate infection in the distal airways.
The combination of small-diameter airway lumens
and the swollen volume of shed cells in the distal
airway regions of hamsters after PIV3-NS2 infection likely contributes to the development of airway occlusion. This finding has clear implications
for RSV infection of human infants, where the very
narrow distal airway lumens of the still-developing
infant lung have been proposed to increase vulnerability of the distal airway regions to obstruction
(29). We did note in our studies that cells shedding
Figure 9
into the hamster lower airways were pleomorphic
Shed epithelial cells infected by PIV3-NS2 into hamster lower conducting airways
resembles shed epithelial cells in RSV-infected human infants. (A) Representative and unusually swollen compared with cells shedding
images from histologic cross sections of hamster distal airways infected with PIV3 from HAE or into the hamster nasal respiratory epiand PIV3-NS2. Sections were stained with H&E, or with antibody against PIV3 to thelium. The differences in morphology and size of
identify PIV3-infected cells, or with an antibody against cytokeratin 18 (CK18) to shed cells following PIV3-NS2 infection may reflect
identify epithelial cells at day 3 pi. Scale bar: 50 μm. (B) Sample images of histologic differences in the responses of epithelial cells distribcross sections of human lower airways obtained postmortem from a patient naturally uted in the lower versus upper airways. Alternatively,
infected by RSV. Sections were stained with H&E, or with an RSV-specific antibody the swollen pleomorphic cells in lower airways may
to detect infected cells, or with a CK8/18 antibody to detect epithelial cells. Scale bar:
represent other epithelial cell types present in the
50 μm. The smaller-diameter distal airways of both hamster and human demonstrate
virus antigen–positive cells that have shed and accumulated in the lumen, often suf- lower but not upper airways, which, when infected by
PIV3-NS2, respond differently to infection compared
ficient to have caused airway occlusion.
with ciliated cells. A potential candidate for such a
cell type is the non-ciliated columnar club (Clara)
by PIV3 caused morphologic changes in infected ciliated cells cell. While club cells are rarely present in the nasal epithelium,
indistinguishable from those infected by RSV. Taken together, they are present in hamster and human lower airways, with club
these findings identify expression of RSV NS2, in the context cell density increasing as airways descend into the distal bronchiof either RSV or PIV3 infection, as sufficient to induce rounded olar airway regions (30, 31). Indeed, while only ciliated cells of the
nasal respiratory epithelium were infected by PIV3 and PIV3-NS2,
morphology in ciliated cells.
We used PIV3-NS2 and control viruses to investigate the signif- in the lower airways, both ciliated and club cells were infected by
icance of these findings in vivo using the hamster model. In the these viruses. RSV also infects both ciliated and non-ciliated cells
hamster nasal cavity, PIV3 recombinant viruses infected only cili- of the lower airways of humans (10, 12), and both cell types are
ated cells of the respiratory epithelium, and only PIV3-NS2 caused infected in the small airways of calves and lambs experimentally
ciliated cell rounding, membrane cytopathology, and cell extrusion, infected with RSV (32, 33). Thus, the differences in morphology
between cells shed into the lower versus upper airways might be
similar to our findings in HAE after RSV or PIV3-NS2 infection.
Infection of the hamster lower airway epithelium with PIV3- due to PIV3-NS2 infection of club cells. Regardless of the specific
NS2, but not PIV3, also resulted in rounding and shedding of epithelial cell types infected by PIV3-NS2 in the different airway
the infected cells from the epithelium into the airway lumen. In regions, we suggest that the combination of smaller diameter of
the large airways of hamsters infected with PIV3-NS2, infected airway lumens in the bronchioles and the expanded volume of
cells shed from the epithelium rarely accumulated in the airway cells shed into these airway regions enhances the likelihood that
lumen, suggesting that the majority of shed cells were rapidly shed cells would accumulate in and occlude distal airways.
Unusual epithelial cell morphology has been described for
and effectively cleared from the lumen, presumably by mechanical airway clearance mechanisms. In the smaller-diameter air- RSV-infected humans and bovine RSV–infected calves (11, 12, 32),
ways, shed cells accumulated in the airway lumen, suggesting and sloughing of virus antigen–positive cells caused small airway
that clearance of shed cells from the small airway lumens was less occlusion in ovine and baboon models of RSV infection (33–35).
efficient compared with clearance from the larger airways. These The loss of cilia and disorganization of cilia basal bodies noted
effects were most pronounced in the small airways of hamsters in human ciliated cells infected by RSV and PIV3-NS2 was also
2 to 3 days after infection by PIV3-NS2, and accumulations of reported in a bovine model of RSV infection (32). Ciliary dyskidetached virus antigen–positive cells were easily detected occlud- nesia and apical membrane damage have been reported in RSVing the small airway lumens, reminiscent of bronchiolar airway infected human ciliated airway epithelium cultures (36). Thus, in
2228
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several appropriate animal models of RSV infection as well as retrospective analysis of human cases of RSV infection, shedding of
pleomorphic, virus antigen–positive epithelial cells, especially in
the smaller-diameter distal airways, appears to be a characteristic
hallmark of RSV infection. We propose that RSV NS2 may be a
major contributor to the development of these early pathologic
findings following RSV infection.
Accumulation of shed cells in the distal lower airways of hamsters infected with PIV3-NS2 suggests that RSV NS2–induced
cell shedding might have importance for the initiation of RSVassociated disease. RSV bronchiolitis is closely associated with
small airway obstruction, resulting in air trapping distal to the
obstruction and increased airway resistance (37, 38). Classically,
the obstructive material has been considered to be a mixture of
necrotic epithelial cells, mucus secretions, and inflammatory
cell exudate. However, autopsy specimens from RSV-infected
patients, including those described in this study, rarely show the
presence of mucus plugs in the small airways but consistently
show unusual pleomorphic epithelial cells positive for virus antigen in the airway lumen. These human autopsy specimens from
patients infected with RSV combined with hamsters infected by
PIV3-NS2 emphasize the potential significance of shed and accumulated epithelial cells as major contributors to small airway
obstruction following RSV infection.
The present study suggests that RSV has an unusual and perhaps unique ability to induce epithelial cell shedding, and that
NS2-induced cell shedding may be an important factor in RSV
pathogenesis. However, the dramatic distal airway plugging in
PIV3-NS2–infected hamsters was transient, as maximal occlusion
occurred at day 3 pi but was cleared by day 5 pi. Obstruction of
small airways was also not associated with increased clinical disease in hamsters. The lack of disease associated with PIV3 (and
RSV) infection in rodent models likely reflects their semi-permissive nature for virus replication, with relatively low whole lung viral
titers and relatively short durations of infection. In contrast, RSV
infection of humans results in substantially higher virus titers,
and virus shedding can continue for up to several weeks (39, 40).
Primary RSV infection in humans is nearly always symptomatic,
and in this more permissive setting, it is reasonable to expect that
RSV NS2–promoted obstruction of small airways with shed epithelial cells would be longer lived, promoting enhanced infection
and inflammation and contributing to increased disease severity.
Interestingly, we also noted that PIV3-NS2 infection was cleared
from hamster lungs more rapidly than was PIV3. This was evident
by histologic analysis, which showed that despite the extensive
infection and airway occlusions associated with PIV3-NS2 on day
3 pi, the infected cells were largely cleared by day 5 pi. In contrast,
in animals infected with PIV3, there were abundant infected cells
on both days 3 and 5 pi. Consistent with this, quantification of
whole lung viral titers confirmed that PIV3-NS2 was cleared more
rapidly than PIV3, even though both viruses reached similar peak
titers by days 2–3 pi.
Previous studies have demonstrated that the RSV NS proteins
enhance viral replication. Recombinant RSV deleted for 1 or both
NS genes resulted in viruses with severely attenuated growth in
vitro and in vivo (41–43). Deletion of either the NS1 or NS2 gene
attenuated human RSV in chimpanzees (42, 44). The NS proteins have also been shown to interfere with a number of antiviral
host responses aimed at reducing the extent of virus replication,
most notably types I and III IFN pathways. The mechanisms by

which NS1 and NS2 inhibit IFN responses are complex, involving
both coordinated and independent functions of the NS proteins
(41, 45–48). Both proteins have also been implicated in inhibiting
apoptosis (49), and RSV NS2 was reported to enhance induction
of NF-κB (19). Although some effects of the NS proteins appear
to involve synergy between NS1 and NS2, this did not appear to
be the case in the present study. Here, the morphologic and shedding phenotype attributed to RSV NS2 appeared to be independent of, and unaffected by, NS1. While the precise mechanism of
NS2-induced morphologic consequences remains unknown, we
speculate that these events are not directly related to the ability of
NS2 to modify IFN responses.
The mechanism by which RSV NS2 exerts its effects on epithelial cell rounding and shedding remains to be explored. Based on
changes in columnar cell morphology, it would be reasonable to
speculate that RSV NS2 may exert effects on cytoskeletal structures. Indeed, RSV has been reported to have effects on intermediate filaments and actin filament structures (50–53). The influence of RSV NS2 on cytoskeletal elements represents a potential
mechanism for cell rounding following RSV infection and will be
the focus of future studies. Comparison of PIV3-NS2 infection of
epithelial cell line monolayers with PIV3 or PIV3-NS1 have thus
far failed to reveal a morphologic phenotype attributable to RSV
NS2 (data not shown), suggesting that the differentiated state of
the columnar airway epithelial cells may be a critical component
of NS2-induced cell rounding. The use of differentiated airway
models such as HAE will therefore be important for understanding how RSV NS2 modifies airway epithelial cells, resulting in the
shedding of infected cells into the airway lumen.
In summary, we present evidence that infection of ciliated cells
in HAE by RSV results in cell rounding, disruption of the cilia
apparatus, active shedding of individual infected cells, and delay
of cell death until infected cells are shed from the epithelium. By
performing loss-of-function and gain-of-function experiments,
we attribute these consequences of infection to the RSV NS2
protein. Using PIV3 as a vector for RSV NS2, we confirmed these
findings in an in vivo hamster model of infection. Expression
of RSV NS2 in vivo resulted in accelerated clearance of infection, and we propose that NS2-induced cell shedding acts as a
novel clearance mechanism to remove infected cells from both
the airway epithelium and the lumen. In the smaller-diameter
distal airways, however, NS2-induced shedding contributed to
acute airway obstruction, which was strikingly reminiscent of
the airway plugging that occurs during RSV bronchiolitis in
infants. Although other respiratory viruses also cause bronchiolitis in young children, we suggest that NS2-mediated cell shedding and subsequent airway obstruction may contribute to the
increased incidence and severity of RSV-associated bronchiolitis
compared with other viral etiologies. The notion that RSV NS2
may be a pathogenesis factor increasing the likelihood of small
airway obstruction as a precursor to bronchiolitis identifies NS2
as a potential therapeutic target for limiting the severity and frequency of RSV bronchiolitis, particularly in infants. It also suggests that deletion of the NS2 gene may be desirable in live-attenuated RSV vaccine candidates (54). Future studies are needed
to explore whether RSV NS2–mediated shedding of infected
cells affects the development of immunity to RSV infection, and
whether manipulation of NS2-promoted epithelial cell shedding
may serve as a therapeutic target for reducing the severity of distal airway disease in RSV-infected infants.
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Methods
Cells
HAE cells were isolated by the University of North Carolina Cystic Fibrosis
Center Cell Culture and Tissue Procurement Core from tracheobronchial
airway specimens obtained from patients, provided by the National Disease
Research Interchange or as excess tissue following lung transplantation. All
protocols were approved by the University of North Carolina at Chapel Hill
Institutional Review Board. Primary epithelial cells derived from single
patient sources were plated on permeable Transwell-Col supports (12-mm
diameter; Corning Inc.) and grown in custom media at an air-liquid interface for 8 to 10 weeks to form differentiated, polarized cultures as previously
described (55). HEp2 cells (ATCC) were maintain in MEM (Gibco) supplemented with 10% fetal bovine serum (Foundation; Gemini Bio-Products).
LLC-MK2 cells (ATCC) were maintained in DMEM (Gibco) supplemented
with 10% fetal bovine serum (Foundation; Gemini Bio-Products).

Animals
In vivo animal studies used Golden Syrian hamsters (Harlan), and all
procedures were conducted in accordance with the NIH Guide for the
Care and Use of Laboratory Animals and using animal study protocols
approved by the Animal Care and Use Committee of the National Institute
of Allergy and Infectious Diseases and the Institutional Animal Care and
Use Committee of the University of North Carolina at Chapel Hill.

Viruses
All viruses used in this study were derived from cDNA (recombinant) and
contain a GFP insertion as an additional gene, unless otherwise mentioned.
Recombinant HMPV (strain CAN97-83), PIV5 (strain W3A; provided by
Robert Lamb, Northwestern University, Evanston, Illinois, USA), and SeV
(provided by Daniel Kolakofsky, University of Geneva School of Medicine,
Geneva, Switzerland) were described previously (56–58). RSV Memphis
37 strain was isolated from a pediatric case of bronchiolitis and has been
described previously (39). This virus is a primary low-passage clinical isolate, not a recombinant virus, and does not express GFP.
Wild-type RSV, RSVΔNS1, RSVΔNS2, and RSVΔNS1/2 are derivatives of
the A2 strain and were constructed and described previously (44, 59–61).
Each of these RSV constructs express the GFP gene as an additional gene
inserted between the RSV P and M genes. Wild-type RSV and all mutants
were amplified in HEp2 cells stably expressing the V gene from SV5 (62).
The SV5-V plasmid was provided by Richard Randall (University of St.
Andrews, St. Andrews, United Kingdom).
PIV3 is a derivative of the JS strain engineered to express the GFP gene
as an additional gene inserted between the PIV3 P and M genes, as has
been described previously (63, 64). Codon-optimized RSV NS1 or NS2
genes were synthesized (DNA2.0) and inserted into the PIV3 viral genome
between the hemagglutinin-neuraminidase (HN) and viral polymerase
(L) genes using cloning methods similar to those previously used to
express CFTR and rhAFP in this genome region (65, 66). A unique EagI
restriction site was generated in the non-coding region downstream
of the HN gene in the PIV3 subgenomic cDNA. The NS1 or NS2 coding sequence was amplified using RT-PCR from plasmids expressing
codon-optimized NS1 or NS2, cloned into a pCR-Blunt II-TOPO vector
(Invitrogen) and sequenced. The following primer sets were used: NS1
sense (5′-CCGCGGCCACCATGGGCAGCAATAGTCTC-3′), NS1 antisense
(5′-GGGCCCGAGTTATGGGTTCAGGTCAA-3′), NS2 sense (5′-CCGCGGCCACAATGGATACCACGC-3′), and NS2 antisense (5′-GGGCCCCTCGAGTCAAGGGTTCAA-3′) (the underlined portions represent SacII and
ApaI restriction sites). Using the SacII and ApaI restriction sites, NS1 or
NS2 was inserted into a vector following a linker sequence consisting
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of the PIV3 gene-end, intergenic, and gene-start transcription regions,
flanked at both ends by EagI sites. This cassette was then inserted using
the EagI sites into the full-length PIV3GFP antigenomic cDNA, and the
resulting genomes were designated PIV3-NS1 or PIV3-NS2. A PIV3 genome
expressing both NS1 and NS2 was also generated by inserting the RSV
NS1 and NS2 genes together into PIV3 between the HN and L genes using
similar methods. From the linker vector containing NS1, a sequence
consisting of the EagI restriction site, PIV3 linker region, and NS1 gene
was PCR amplified using the NS1 sense primer (5′-CGAATTGGCGGCCGAAAATA-3′) and the NS1 antisense primer (5′-CAGGAGTTCAGCACGATGGGGGCCCGAGTTATGGGT-3′), destroying the 3′ EagI site
and creating an 18-bp overhang. From the linker vector containing NS2,
a sequence consisting of the PIV3 linker region, the NS2 gene, and the
EagI restriction site was amplified using the NS2 sense primer (5′-GCTGAACTCCTGCATCGTAAAATAAGAAAAACTTAG-3′) and the NS2 antisense primer (5′-ACTTGGCCCAAGCTTGAGTA-3′), destroying the 5′ EagI
site and adding the complementary 18-bp overhang. These 2 fragments
were combined in a fusion reaction using the NS1 sense and NS2 antisense primers, and the resulting fragment was cloned into a pCRBluntII
TOPO vector (Invitrogen) and sequenced. The final fragment consisted of
a PIV3 linker region, the RSV NS1 gene, a second PIV3 linker region, and
the RSV NS2 gene, flanked by EagI sites. This cassette was then inserted
using the EagI sites into the full-length PIV3GFP antigenomic cDNA, creating PIV3-NS1/2. Each insert was designed to retain the “rule of 6,” in
which a genome length with a multiple of 6 nucleotides is required for
PIV3 genome replication. All viruses were rescued and amplified in LLCMK2 cells using methods described previously (63) and sequenced.

Viral inoculations and growth
In vitro studies. The apical surfaces of HAE were rinsed with PBS to remove
excess airway secretions. Virus inoculum diluted in serum-free DMEM
(Gibco; 100 μl per 12 mm well) was applied to the apical surface of HAE for
2 hours at 37°C, then removed by aspiration. The apical surfaces were rinsed
with PBS, and the cultures were incubated at 37°C. Viral growth kinetics
were determined by performing apical surface washes with 300 μl of serumfree DMEM, which were harvested after 30 minutes at 37°C and stored
at –80°C until analysis. RSV viral titers in the apical washes were determined on HEp2 cells by titration and counting GFP-positive cells 24 hours
pi. PIV3 viral titers were determined using a 50% tissue culture infectious
dose (TCID50) assay on LLC-MK2 cell monolayers, with positive wells scored
by GFP expression. En face fluorescent images of GFP-positive cells in
HAE were captured using a Leica DMIRB Inverted Fluorescent Microscope
equipped with a Retiga 1300 CCD camera (Q-Imaging). The proportion of
the surface area of epithelium positive for GFP was determined by pixelating
a black-and-white image, calculating the percentage of black pixels using
ImageJ software (NIH) for 5 fields per culture, and averaging the results.
In vivo studies. Ten- to twelve-week-old female Golden Syrian hamsters
(Harlan) were transiently anesthetized (methoxyflurane) and inoculated
intranasally with 106 PFU of PIV3, PIV3-NS1, or PIV3-NS2 in 100 μl serumfree L-15 Leibovitz medium (Gibco). Animals were euthanized and respiratory tissues harvested at the pi times indicated in the figures, for analysis
of virus titers or histologic assessment. For virus titrations, whole lungs or
nasal turbinates were weighed and homogenized in PBS. Viral titers were
determined by standard plaque assay of the clarified supernatants, as previously described (67).

Histology and immunoprotocols
HAE cultures fixed in 4% paraformaldehyde in PBS were paraffin
embedded, and 5-μm-thick histological sections were prepared. Sections were stained with H&E or Richardson’s stain. Immunodetection
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of RSV antigen and β-tubulin IV was performed by blocking sections in
3% BSA in PBS, followed by incubation with primary antibodies against
GFP (rabbit polyclonal; Abcam) and β-tubulin IV (mouse monoclonal;
Sigma-Aldrich). Immunoreactivity was detected using an anti-rabbit
IgG conjugated to Alexa Fluor 488 and an anti-mouse IgG conjugated
to Alexa Fluor 594 (Molecular Probes). To preserve and visualize apical secretions of HAE, cultures were fixed in the alcohol-based fixative
Omnifix (FR Chemical) as previously described (68) and stained with
H&E. Immunohistochemistry for viral antigens were performed by
blocking sections in 3% BSA and incubating with primary antibodies against RSV (anti-RSV goat polyclonal; Meridian Life Sciences) or
PIV3 (anti-PIV3 rabbit serum raised against sucrose-gradient-purified PIV3; ref. 69). Immunoreactivity was detected using anti-goat or
anti-rabbit secondary antibodies conjugated to HRP, visualized using
3,3′-diaminobenzidine (Sigma-Aldrich), and counterstained with hematoxylin. For TEM studies, HAE cultures were fixed in glutaraldehyde
solution, then in an osmium tetroxide solution to preserve the hydrated
external environment of the HAE, as previously described (68), and visualized using standard TEM techniques.
For histologic examination of hamster tissues, excised nasal turbinates
or whole lungs were immersion-fixed in 10% neutral-buffered formalin
and embedded in paraffin, and histological sections were generated for
examination and staining. Sections were stained with H&E. Immunodetection of viral antigen was performed using the anti-PIV3 rabbit serum
mentioned above. To identify epithelial cells, a cytokeratin 18 antibody
was used (mouse monoclonal; Abcam). Primary antibodies were detected
using anti-mouse or anti-rabbit antibodies conjugated to HRP (Jackson
ImmunoResearch Laboratories), visualized using 3,3′-diaminobenzidine
(Sigma-Aldrich), and counterstained with hematoxylin.
RSV infection in human airways was determined in lung tissue obtained
from infants with complete DiGeorge Syndrome naturally infected by
RSV, and tissue was provided by the Duke University Pathology Specimen Repository in accordance with Duke University IRB protocols. RSV
and cytokeratin 8/18 immunoreactivity was performed on histological
sections using a Leica Bond-III automated stainers (Leica Microsystems
Inc.). Following antigen retrieval with Novocastra Bond Epitope Retrieval
1 solution (Leica Microsystems), sections were incubated with a primary
antibody against RSV antigen (clones 5H5N, 2G12, 5A6, IC3; Vector Laboratories) and detected with the Novocastra Bond Polymer Refine Detection system (Leica Microsystems). Immunostaining for cytokeratin 8/18
used a proteinase K epitope retrieval solution (Dako North America Inc.),
the primary antibody Novocastra cytokeratin 8/18 monoclonal antibody
(clone 5D3; Leica Microsystems), and detection with the Novocastra Bond
Polymer Refine Detection system.

Morphometric analysis of cell height and airway occlusion
XZ confocal images were acquired using a Leica SP5 confocal microscope.
XZ images through the tallest region of a GFP-positive infected cell in fixed
but unprocessed HAE cultures were imported into ImageJ software (NIH),
where pixel height was measured and converted to microns using the electronic magnification measurement bar from the confocal image. A minimum of 100 infected cells were measured from at least 3 individual donors.
The height of infected cells in the nasal respiratory tissue was determined
by measuring pixel height of infected cells in images from fixed, viral antigen–stained sections using ImageJ software (NIH) and converting to microns.
Occlusion of airways was determined by imaging infected airway regions
from fixed, viral antigen–stained sections, converting to black-and-white
images, pixelating, and calculating the percentage of black pixels within
the airway lumen using ImageJ software. Airway occlusions were measured
from 6 individual animals harvested on day 3 pi. All airways with antigen-

positive cells (mean: ~30 airways per animal), except those larger than
1 mm in diameter (~1 airway per animal), were measured, regardless of
number of infected cells or extent of infection per airway.

Cell shedding
Cell shedding was quantified by determining the amount of dsDNA in apical washes of HAE using the Quant-It PicoGreen dsDNA kit (Invitrogen).
Apical washes were performed with 300 μl serum-free DMEM for 30 minutes at 37°C. Washes were harvested and stored at –80°C prior to analysis. Samples were diluted 5-fold in Tris-EDTA buffer, and dsDNA was
measured in duplicate following the manufacturer’s instructions using
a 96-well plate format. dsDNA concentration per sample was calculated
based on fluorescence of a titrated dsDNA standard.

Percentage of area ciliated
Following removal of apical washes for titer and cell shedding assays, HAE
cultures were allowed to come to room temperature for 15 minutes to
normalize cilia beat frequency, and 100 μl PBS was added apically. HAE
cultures were placed on an inverted phase contrast microscope (TE2000;
Nikon) using a ×20 objective, and high-speed (125-Hz) video images were
captured with an 8-bit black-and-white camera (GS-310 Turbo; Megaplus).
The analog signal was digitized via an analog-to-digital converter board
(A/D; National Instruments). A digital computerized analysis system was
used to analyze the acquired video images, using software based on SissonAmmons Video Analysis (70).

MCT rates
Following removal of apical washes for titer and shedding assays, green fluorescent microspheres (0.02% vol/vol, 1 μm; Invitrogen) were added to the
apical surface and HAE cultures were incubated at 37°C. Time-lapse fluorescent images were obtained for 3 s using a Leica DMIRB Inverted Fluorescent Microscope equipped with a Retiga 1300 charge-coupled device
camera (Q-Imaging). The rate of microsphere displacement was calculated
as previously described (65).

Statistics
Statistical analysis of the data was performed using 2-tailed unpaired t
test, ANOVA, or Mann-Whitney U test, as indicated in the figure legends.
P < 0.05 was considered statistically significant unless otherwise noted.

Study approval
Protocols for the use of animals in these studies were reviewed and
approved by the University of North Carolina at Chapel Hill IACUC
(approval ID 11-118.0) and the Animal Care and Use Committee of the
National Institute of Allergy and Infectious Diseases (NIAID ASP LID34E).
Protocols for human cell culture were reviewed by the University of North
Carolina at Chapel Hill Office of Human Research Ethics, which determined that the use of cells did not constitute human subject research as
defined under federal regulations (45 CFR 46.102 [d or f] and 21 CFR
56.102[c][e][l]) and did not require institutional review board approval.
Protocols for using existing human autopsy specimens were reviewed by
the Duke University Institutional Review Board, which determined that
the protocols met the definition of research not involving human subjects
as described in 45 CFR 46.102(f), 21 CFR 56.102(e), and 21 CFR 812.3(p)
and satisfied the Privacy Rule as described in 45CFR164.514.
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